Macrophage Migration-inhibitory Factor Levels in Serum of Patients with Ovarian Cancer Correlates with Poor Prognosis

Ovarian cancer is generally thought of as a cancer with poor prognosis. However, prognostic appraisal of the disease is based on tumor stages, surgical features or sensibility towards platinum-based chemotherapy. There are data that also grant immunological parameters such as CD8(+) T-lymphocyte-(CD...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anticancer research 2012-12, Vol.32 (12), p.5233-5238
Hauptverfasser:	KROCKENBERGER, Mathias, KRANKE, Peter, HÄUSLER, Sebastian, ENGEL, Jörg Bernhard, HORN, Evi, NÜRNBERGER, Katharina, WISCHHUSEN, Jorg, DIETL, Johannes, HÖNIG, Arnd
Format:	Artikel
Sprache:	eng
Schlagworte:	Antitumor activity Ascites Biological and medical sciences Biomarkers, Tumor - blood Case-Control Studies CD8 antigen CD8-Positive T-Lymphocytes - pathology Chemotherapy Data processing Disease-Free Survival Enzyme-Linked Immunosorbent Assay Female Female genital diseases Gynecology. Andrology. Obstetrics Humans Immune response Killer Cells, Natural - pathology Lymphocytes T Lymphocytes, Tumor-Infiltrating - pathology Macrophage migration inhibitory factor Macrophage Migration-Inhibitory Factors - blood Macrophages Medical sciences Metastases Natural killer cells Ovarian cancer Ovarian Neoplasms - blood Ovarian Neoplasms - immunology Ovarian Neoplasms - pathology Platinum Prognosis Retrospective Studies Stromal Cells - pathology Survival Rate Tumor cells Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!